Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 3Thoracic 1Dermatologic 1CNS 1

Conditions

Melanoma 44Brain Neoplasms 22Carcinoma, Renal Cell 10Neoplasm Metastasis 9Sarcoma 7Lung Neoplasms 7Carcinoma, Non-Small-Cell Lung 7Breast Neoplasms 7Uveal Melanoma 5Gastrointestinal Neoplasms 4Small Cell Lung Carcinoma 3Kidney Neoplasms 3Colorectal Neoplasms 3Carcinoma, Merkel Cell 3Urinary Bladder Neoplasms 2Thyroid Neoplasms 2Spinal Cord Compression 2Skin Neoplasms 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Neoplasms 2Head and Neck Neoplasms 2Colonic Neoplasms 2Carcinoma, Transitional Cell 2Uterine Cervical Neoplasms 1Testicular Neoplasms 1Stomach Neoplasms 1Recurrence 1Rectal Neoplasms 1Radiation Injuries 1

Interventions

Specimen Handling 2Nivolumab 2atezolizumab 1Tissue Banks 1Radiosurgery 1Magnetic Resonance Spectroscopy 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Clear-cell metastatic renal cell carcinoma × Radiosurgery × Dermatologic × Clear all
NCT02978404 2024-06-28

Combining Radiosurgery and Nivolumab in the Treatment of Brain Metastases

Centre hospitalier de l'Université de Montréal (CHUM)

Phase 2 Completed
26 enrolled
CNSDermatologicGenitourinaryThoracic

Clear-cell metastatic renal cell carcinoma, Brain Neoplasms, Melanoma, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡